AQR Arbitrage’s Acceleron Pharma XLRN Stock Holding History

AQR Arbitrage’s Portfolio XLRN Stock Details XLRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-41,122	Closed	-$7.08M	–	1470
2021 Q3	$7.08M	Buy	+41,122	New	+$5.38M	0.2%	125

AQR Arbitrage's XLRN Position: Q4 2021 in Review

AQR Arbitrage sold out of Acceleron Pharma (XLRN) in Q4 2021, closing a stake of 41,122 shares — an estimated $7.08M sold.

AQR Arbitrage first reported a position in XLRN in Q3 2021 and held it in 1 quarter. The position peaked at $7.08M in Q3 2021. 1 fund tracked by Wall St. Rank holds XLRN as of Q4 2021.

AQR Arbitrage reported no remaining Acceleron Pharma position as of Q4 2021 after selling out during the quarter.
AQR Arbitrage sold 41,122 Acceleron Pharma shares in Q4 2021, an estimated $7.08M.
AQR Arbitrage first reported a position in Acceleron Pharma in Q3 2021 and held it in 1 quarter.
AQR Arbitrage's Acceleron Pharma position peaked at $7.08M in Q3 2021.
1 fund tracked by Wall St. Rank held Acceleron Pharma as of Q4 2021.

Based on AQR Arbitrage's 13F filing for Q4 2021, filed 14 Feb 2022.